|
[1]JIANG H, CHESS L.Regulation of immune responses by T cells[J].N Engl J Med, 2006, 354 (11) :1166-1176.
|
|
[2]OKUMURA A, ISHIKAWA, SATO S, et al.Deficieccy of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4 (+) CD25 (+) T cells in patients with autoimmune hepatitis[J].Hepatol Res, 2008, 38 (9) :896-903.
|
|
[3]PEISELER M, SEBODE M, FRANKE B, et al.FOXP3+regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency[J].J Hepatol, 2012, 57 (1) :125-132.
|
|
[4]LONGHI MS, MA Y, MIELI-VERGANI G, et al.Regulatory T cells in autoimmune hepatitis[J].J Hepatol, 2012, 57 (4) :932-933.
|
|
[5]ZHAO L, TANG Y, YOU Z, et al.Interleukin-17 contributes to the pathogenesis of autoimune hepatitis through inducing hepatic in Interleukin-6 expression[J].PLoS One, 2011, 6 (4) :e18909.
|
|
[6]WEI LL, ZHOU L, SHI HB, et al.Role of Th17 cells in common liver disease[J].J Clin Hepatol, 2013, 29 (6) :477-480. (in Chinese) 魏琳琳, 周莉, 时红波, 等.Th17在常见肝脏疾病中的作用[J].临床肝胆病杂志, 2013, 29 (6) :477-480.
|
|
[7]LIU JT.Clinical application and diagnostic significance of autoantibody detection in autoimmune liver diseases[J].Immunol J, 2013, 29 (3) :267-269. (in Chinese) 刘金涛.自身抗体测定在临床自身免疫性肝病中的作用和诊断意义[J].免疫学杂志, 2013, 29 (3) :267-269.
|
|
[8]WANG QX, JIANG WJ, MIAO Q, et al.Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients:a single center experience[J].J Dig Dis, 2013, 14 (4) :175-180.
|
|
[9]CZAJA AJ.Drug choices in autoimmune hepatitis:part A-Steroids[J].Expert Rev Gastroenterol Hepatol, 2012, 6 (5) :603-615.
|
|
[10]CZAJA AJ.Nonstandard drugs and feasible new interventions for autoimmune hepatitis:partⅡ[J].Inflamm Allergy Drug Targets, 2012, 11 (5) :351-363.
|
|
[11]LIU JZ, ALMARRI MA, GAFFNEY DJ, et al.Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis[J].Nat Genet, 2012, 44 (10) :1137-1141.
|
|
[12]LLEO A, LIAO J, INVERNIZZI P, et al.Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis[J].Hepatology, 2012, 55 (1) :153-160.
|
|
[13]HIRSCHFILED GM, INVERNIZZI P.Progress in the genetics of primary biliary cirrh-osis[J].Semin Liver Dis, 2011, 31 (2) :147-156.
|
|
[14]ZHANG Y, CHEN WZ, WANG WM, et al.Effect of estrogen receptorαgene polymorp-hism on the variations of T lymphocyte subsets and its related cell factors within female primary cholestasis cirrhosis patient[J].Chin J Clinicians:Electronic Edition, 2010, 4 (7) :954-961. (in Chinese) 张嫣, 陈伟忠, 王伟民, 等.雌激素受体α基因多态性对女性原发性胆汁淤积性肝硬化患者T细胞亚群及其相关细胞因子变化影响的研究[J].中华临床医师杂志:电子版, 2010, 4 (7) :954-961.
|
|
[15]LIANG Y, YANG Z, ZHONG R.Smoking, family history and urinary tract infection are associated with primary biliary cirrhosis:a meta-analysis[J].Hepatol Res, 2011, 41 (6) :572-578.
|
|
[16]NINOMIVA M, UENO Y, SHIMOSEGAWA T.PBC:Animal models of cholangiopathies and possible endogenous viral infections[J].Int J Hepatol, 2012, 2012:649290.
|
|
[17]SELMI C, BOWLUS C, GERSHWIN ME, et al.Primary biliary cirrhosis[J].Lancet, 2011, 377 (9777) :1600-1609.
|
|
[18]SHI J, YUAN SM, LI P, et al.Level and significance of detection of primary biliary cir-rhosis patients with serum MIP-3αand IL-17A[J].Chin J Clin Lab Sci, 2013, 31 (2) :96-98. (in Chinese) 史静, 袁世梅, 李朴, 等.检测原发性胆汁性肝硬化患者血清MIP-3α与IL-17A的水平及意义[J].临床检验杂志, 2013, 31 (2) :96-98.
|
|
[19]KHAN F, KOMARLA AR, MENDOZA PG, et al.Keratin 19 demonstration of canal of Hering loss in primary biliary cirrhosis:”minimal change PBC”?[J].Hepatology, 2013, 57 (2) :700-707.
|
|
[20]ANGULO P, JORGENSEN RA, KEACH JC, et al.Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid[J].Hepatology, 2000, 31 (2) :318-323.
|
|
[21]RITZEL U, LEONHARDT U, NATHER M, et al.Simvastatin in primary biliary cirrhosis:effects on serum lipids and distinct disease markets[J].J Hepatol, 2002, 36 (6) :454-458.
|
|
[22] TSUDA M, MORITOKI Y, LIAN ZX, et al.Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid[J].Hepatology, 2012, 55 (2) :512-521.
|
|
[23]HOU XM, JIN EH, ZHANG J, et al.Magnetic resonance cholangiopancreatographic features of primary sclerosing cholangitis[J].Chin J Med Imaging Technol, 2013, 29 (10) :1670-1673. (in Chinese) 侯新萌, 靳二虎, 张洁, 等.原发性硬化性胆管炎的磁共振胰胆管成像表现[J].中国医学影像技术, 2013, 29 (10) :1670-1673.
|
|
[24]WANG QY, LIU WQ.One case report of Traditional Chinese Medicine treatment of primary sclerosing cholangitis[J].J Changchun Univ Tradit Chin Med, 2012, 28 (1) :89-90. (in Chinese) 王庆艳, 刘文全.中医药治疗原发性硬化性胆管炎1例[J].长春中医药大学学报, 2012, 28 (1) :89-90.
|
|
[25]BERGQUIST A, MONTGOMERY SM, BAHMANYAR S, et al.Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis[J].Clin Gastroenterol Hepatol, 2008, 6 (8) :939-943.
|
|
[26]POLLHEIMER MJ, HALILBASIC E, FICKERT P, et al.Pathogenesis of primary scl-erosing cholangitis[J].Best Pract Res Clin Gastroenterol, 2011, 25 (6) :727-739.
|
|
[27]RIGOPOULOU EI, SMYK DS, MATTHEWS CE, et al.Epsteinbarr virus as a trigger of autoimmune liver diseases[J].Adv Virol, 2012, 2012:987471.
|
|
[28]NAVANEETHAN U, VENKATESH PG, CHOUDHARY M, et al.Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis[J].J Crohns Colitis, 2013, 7 (2) :e35-e41.
|
|
[29]KATO T, KOMORI A, BAE SK, et al.Concurrent systemic AA amyloidosis can discriminate primary sclerosing cholangitis from IgG4-associated cholangitis[J].World J Gastroenterol, 2012, 18 (2) :192-196.
|
|
[30]KRONES E, GRAZIADEI I, TRAUNER M, et al.Evolving concepts in primary sclerosing cholangitis[J].Liver Int, 2012, 32 (3) :352-369.
|
|
[31]OTHMAN MO, DUNKELBERG J, ROY PK.Urosdeoxycholic acid in primary sclerosing cholangitis:a meta-analysis and systematic review[J].Arab J Gastroenterol, 2012, 13 (3) :103-110.
|
|
[32]SINGH S, KHANNA S, PARDI DS, et al.Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatoy bowel disease:a systematic review and meta-analysis[J].Inflamm Bowel Dis, 2013, 19 (8) :1631-1638.
|
DownLoad: